Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma

Clinical Cancer Research

Volumn 13, Issue 18, 2007, Pages 5348-5354

  Matta, Giorgia Maria Elena ^a,b   Battaglio, Silvano ^b   Dibello, Cristiana ^a   Napoli, Patrizia ^c   Baldi, Cristina ^b   Ciccone, Giovannino ^b   Coscia, Marta ^a,b   Boccadoro, Mario ^a   Massaia, Massimo ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Ospedale Evangelico Valdese   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANEMIA; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMOPATHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PROGNOSIS;

EID: 34848822335     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2819     Document Type: Article

References (40)

1. Pruzansky W, Gidon MS, Roy A. Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis. Clin Immunol Immunopathol 1980;17:280-6.
2. Ticky Hrncir Z, Simsa J. Serum levels of IgA, IgM, IgD and IgE in IgG paraproteinaemias. Haematologia (Budap) 1977;11:79-83.
3. Grove DI, Burston TO, Forbes IJ. Serum IgE levels in paraproteinaemia. Int Arch Allergy Appl Immun 1975;49:564-67.
4. Tamir R, Barchat I, Weiss H, Pick AI. IgE response in multiple myeloma. Ann Allergy 1993;70:214-7.
5. Maldonado-Lopez R, Moser M. Dendritic cells subsets and the regulation of Th1/Th2 responses. Semin Immunol 2001;13:275-82.
6. O'Hehir RE, Garman RD, Greenstein JL, Lamb JR. The specificity and regulation of T-cell responsiveness to allergens. Annu Rev Immunol 1991;9:67-95.
7. Garraud O, Nkenfou C, Bradley JE, Perler FB, Nutman TB. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 1995;155:1316-25.
8. Sudowe S, Rademaekers A, Kolsch E. Antigen dose-dependent predominance of either direct or sequential switch in IgE antibody responses. Immunology 1997;91:464-72.
9. Valle A, Zuber CE, Defrance T, Djossou O, De RM, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989;19:1463-7.
10. Barbee RA, Halonen M, Lebowitz M, Burrows B. Distribution of IgE in a community population sample: correlations with age, sex and allergen skin test reactivity. J Allergy Clin Immunol 1981;68:106-11.
11. Barbee RA, Halonen M, Kaltenborn W, Lebowitz M, Burrows B. A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking and atopic status. J Allergy Clin Immunol 1987;79:919-27.
12. Klink M, Cline MG, Halonen M, Burrows B. Problems in defining normal limits for serum IgE. J Allergy Clin Immunol 1990;85:440-4.
13. Omenaas E, Bakke P, Elsayed S, Hanoa R, Gulsvik A. Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors. Clin Exp Allergy 1994;24:530-9.
14. Geha RS, Rappaport JM, Twarog FJ, Parkman R, Rosen FS. Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation. J Allergy Clin Immunol 1980;66:78-81.
15. Bengtsson M, Gordon J, Flores-Romo L, et al. TH B-cell reconstitution after autologous bone marrow transplantation: increase in serum CD23 ("IgE-binding factor") precedes IgE and B-cell regeneration. Blood 1989;73:2139.
16. Massaia M, Borrione P, Battaglio S, et al. Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood 1999;94:673-83.
17. Coscia M, Mariani S, Battaglio S, et al. Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy. Leukemia 2004;18:139-45.
18. Wrensch M, Wiencke JK, Wiemels J, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006;66:4531-41.
19. Frassanito MA, Cusmai A, Dammacco F. Deregulated cytokine network and defective Th1 immune response in multiplemyeloma. Clin Exp Immunol 2001;125:190-7.
20. Yi Q, Osterborg A, Bergenbrant S, Mellstedt H, Holm G, Lefvert AK. Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood 1995;86:3043-9.
21. Yi Q, Osterborg A. Idiotype-specific T cells in multiple myeloma: targets for an immunotherapeutic intervention? Med Oncol 1996;13:1-7.
22. Holly EA, Eberle CA, Bracci PM. Prior History of Allergy and Pancreatic Cancer in the San Francisco Bay Area. Am J Epidemiol 2003;158:432-41.
23. La Vecchia C, D'Avanzo B, Negri E, Franceschi F. History of selected disease and the risk of colorectal cancer. Eur J Cancer 1991;27:582-6.
24. Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results fromth e international adult brain tumour study. Int J Cancer 1999;82:155-60.
25. Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumor in adults. Int J Cancer 2002;106:423-8.
26. Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003;105:255-60.
27. Severson RK, Davis S, Thomas DB, Stevens RG, Heuser L, Sever LE. Acute myelocytic leukemia and prior allergies. J Clin Epidemiol 1989;42:995-1001.
28. Linet MS, McCaffrey LD, Humphrey RL, et al. Chronic lymphocytic leukemia in adults: a case-control study in Yorkshire. Leukemia 1988;2:687-90.
29. Wiemels JL, Wiencke JK, Patoka J, et al. Reduced Immunoglobulin E and Allergy among Adults with Glioma Compared with Controls. Cancer Res 2004;64:8468-73.
30. Osterborg A, Henriksson L, Mellstedt H. Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma. Acta Oncol 2000;39:797-800.
31. Liu YJ, Cairns JA, Holder MJ, et al. Recombinant 25-kDa CD23 and interleukin la promote the survival of germinal center B cells: Evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991;21:1107-14.
32. Luo HY, Hofstetter H, Banchereau J, Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J Immunol 1991;146:2122-9.
33. Huang N, Kawano MM, Mahm oud MS, et al. Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells. Blood 1995;85:3704-12.
34. Mitsiades CS, Mitsiades NS, Munshi NC, Richardson PG, Anderson KC. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions. Eur J Cancer 2006;42:1564-73.
35. Kimata H, Yoshida A, Ishioka C, Mikawa H. Effect of recombinant human erythropoietin on human IgE production in vitro. Clin Exp Immunol 1991;83:483.
36. Zhai XW, Wu Y, Gu XF, Lu FJ. Relationship between tumor necrosis factor α, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor α on erythropoietin gene expression. Zhonghua Er Ke Za Zhi 2004;42:62-5.
37. Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-γ, TNF-α, IL10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 2003;14:1776-84.
38. Rokicka-Piotrowicz M, Paszkowska M, Krol M, Krol M, Kuratowska Z. Analysis of causes of anemia in patients with multiple myeloma. Pol Arch Med Wewn 2000;104:843-51.
39. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004;18:1176-99.
40. Bacharier LB, Geha RS. Molecular machanisms of IgE regulation. J Allergy Clin Immunol 2000;105:547-58.